Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Rowinsky

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Seminars in Oncology|January 13, 1998
Review of phase I clinical studies with topotecanE K Rowinsky, J Verweij
Hematology/Oncology Clinics of North America|August 1, 1997
Experimental chemotherapeutic agents for the treatment of colorectal carcinomaS O'Reilly, E K Rowinsky
Critical Reviews in Oncology/Hematology|September 1, 1996
The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996S O'Reilly, E K Rowinsky
Oncogene|June 28, 2001
The rapamycin-sensitive signal transduction pathway as a target for cancer therapyM Hidalgo, E K Rowinsky
Seminars in Oncology|August 1, 1993
The clinical pharmacology of paclitaxel (Taxol)E K Rowinsky, R C Donehower
Pharmacology & Therapeutics|October 1, 1991
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeuticsE K Rowinsky, R C Donehower
Seminars in Oncology|June 1, 1991
Old drugs revisited, new drugs, and experimental approaches in ovarian cancer therapyW P McGuire, E K Rowinsky
The Annals of Pharmacotherapy|May 1, 1994
Patient care issues: the management of paclitaxel-related toxicitiesR S Finley, E K Rowinsky
Cancer Treatment Reviews|January 1, 1993
An overview of experience with TAXOL (paclitaxel) in the U.S.AR C Donehower, E K Rowinsky
Seminars in Oncology|September 12, 2001
Pharmacokinetic profiles of doxorubicin in combination with taxanesF A Holmes, E K Rowinsky
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Seminars in Oncology|January 13, 1998
Review of phase I clinical studies with topotecanE K Rowinsky, J Verweij
Hematology/Oncology Clinics of North America|August 1, 1997
Experimental chemotherapeutic agents for the treatment of colorectal carcinomaS O'Reilly, E K Rowinsky
Critical Reviews in Oncology/Hematology|September 1, 1996
The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996S O'Reilly, E K Rowinsky
Oncogene|June 28, 2001
The rapamycin-sensitive signal transduction pathway as a target for cancer therapyM Hidalgo, E K Rowinsky
Seminars in Oncology|August 1, 1993
The clinical pharmacology of paclitaxel (Taxol)E K Rowinsky, R C Donehower
Pharmacology & Therapeutics|October 1, 1991
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeuticsE K Rowinsky, R C Donehower
Seminars in Oncology|June 1, 1991
Old drugs revisited, new drugs, and experimental approaches in ovarian cancer therapyW P McGuire, E K Rowinsky
The Annals of Pharmacotherapy|May 1, 1994
Patient care issues: the management of paclitaxel-related toxicitiesR S Finley, E K Rowinsky
Cancer Treatment Reviews|January 1, 1993
An overview of experience with TAXOL (paclitaxel) in the U.S.AR C Donehower, E K Rowinsky
Seminars in Oncology|September 12, 2001
Pharmacokinetic profiles of doxorubicin in combination with taxanesF A Holmes, E K Rowinsky
Pageof 16